BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  AlloVir Reports Full-Year 2021 Financial Results and 2022 Outlook

  AlloVir (Nasdaq: ALVR), a late clinical-stage allogeneic T cell immunotherapy company, today reported full-year 2021 financial results for the period ended December 31, 2021.

  February 10, 2022

   · 

  11 min read
• Genetown

  Enanta Pharmaceuticals to Present at the SVB Leerink 11th Annual Global Healthcare Conference

  Enanta Pharmaceuticals, Inc. announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 3:00 p.m. ET.

  February 10, 2022

   · 

  1 min read
• Biotech Bay

  Latina-Led Respira Labs Raises $2.8 Million to Revolutionize Respiratory Care for COPD, COVID-19 and Asthma Patients

  Respira Labs today announces it has closed $2.8 million to continue to develop and produce its chest wearable that uses acoustic resonance to assess lung function and identify changes in lung air volume, which is especially critical for COPD, COVID-19, and asthma patients.

  February 10, 2022

   · 

  3 min read
• Business

  Labcorp Announces 2021 Fourth Quarter and Full-Year Results

  Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2021, full-year 2022 guidance and longer-term outlook.

  February 10, 2022

   · 

  25 min read
• Business

  CureVac Doses First Participant in Phase 1 Study with Multivalent Influenza Vaccine Candidate Based on Second-Generation mRNA Backbone Developed in Collaboration with GSK

  CureVac N.V. today announced that it has dosed the first participant in a Phase 1 study of its seasonal influenza second-generation mRNA vaccine candidate, CVSQIV, developed in collaboration with GSK.

  February 10, 2022

   · 

  6 min read
• BioCapital

  OpGen Announces Successful Completion of Unyvero A30 Development Milestone

  OpGen, Inc. announced today that its subsidiary Curetis has successfully met a key milestone in the development of the new Unyvero A30 RQ platform instruments.

  February 10, 2022

   · 

  5 min read
• Business

  InMed Pharmaceuticals to Report Second Quarter Fiscal 2022 Financial Results and Business Update on February 15, 2022

  InMed Pharmaceuticals Inc. will report financial results on Tuesday, February 15, 2022 for the second quarter of fiscal year 2022, ending December 31, 2021.

  February 10, 2022

   · 

  2 min read
• Biotech Beach

  Kura Oncology to Participate in SVB Leerink Global Healthcare Conference

  Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced its participation in the 11th Annual SVB Leerink Global Healthcare Conference.

  February 10, 2022

   · 

  1 min read
• Business

  Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer

  Generation Bio Co. announced the promotion of Antoinette Paone to chief operating officer (COO).

  February 10, 2022

   · 

  9 min read
• Pharm Country

  ContraFect to Present at the SVB Leerink 11th Annual Global Healthcare Conference

  ContraFect Corporation announces that Roger Pomerantz, M.D., President, Chief Executive Officer and Chairman of ContraFect, will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference, which is being held virtually from February 14–18, 2022.

  February 10, 2022

   · 

  4 min read